Terry Parlett

Terry Parlett is the current Non-Executive Director at DIOSynVax. Terry has also held positions at Cambridge Enterprise, SPOTON CLINICAL DIAGNOSTICS LIMITED, and Guy's and St Thomas'​ NHS Foundation Trust. Terry has been in their current position since 2018.

Terry Parlett has over 20 years of experience in technology transfer and commercial research. Terry has a proven track record in taking inventions and discoveries to market via licensing deals or formation of spin-out companies. Terry has also been responsible for public-private (translational) research partnerships and fee for service research and consultancy revenues.

Some of the technologies that Terry Parlett has commercialized include molecular diagnostics, medical devices, novel formulations and biological therapies, biomarkers, imaging hardware and software, digital health and health related software tools.

Terry Parlett received their PhD in immunology from King's College London. Terry also has a BSc in molecular therapeutics, biophysics, and cell therapies from the same school. Terry is currently a professor at CCHS.